人工智能辅助诊断和膀癌的组织病理学分级:当前的状况,挑战和未来的方向
Lihao Zhang1, Yinghao Zhong1,2, Gang Yang1
1North Sichuan Medical College, Nanchong, China.
Frontiers in digital health
|February 23, 2026
概括
人工智能 (AI) 在改善膀癌诊断和分级方面表现有前途,克服了传统方法的局限性. 这篇评论强调了人工智能.
科学领域:
- 尿道瘤学 尿道瘤学
- 人工智能在医学中的应用
- 数字病理学数字病理学
背景情况:
- 膀癌的诊断和分级对于患者的管理和预后至关重要.
- 传统的诊断方法表现出显著的主观性和观察者之间的变化.
- 人工智能 (AI),特别是深度学习 (DL),为客观分析提供了潜力.
研究的目的:
- 系统地审查人工智能应用在膀癌诊断和分级方面的最新进展.
- 讨论人工智能在膀癌管理中的挑战和未来方向.
主要方法:
- 对人工智能在膀癌中的应用进行了全面的文献审查.
- 专注于人工智能在成像分析,数字病理学和分子标记物识别方面.
- 分析人工智能驱动的临床决策支持系统.
主要成果:
- 人工智能在提高膀癌诊断和组织病理学分级的准确性方面显示出显著的潜力.
- 人工智能应用包括图像分析,数字病理学和生物标志物识别.
- 人工智能驱动的决策支持工具正在为临床实践出现.
结论:
- 人工智能将彻底改变膀癌的诊断和分级,提高准确性并减少主观性.
- 解决数据质量,概括性和解释性等挑战对于临床翻译至关重要.
- 未来的方向包括多式联络人工智能,生物标志物集成和个性化瘤学的智能决策支持.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


